Nautilus

Challenge

How do you publicly debut a company driving the proteomic revolution and build a platform narrative durable enough to carry a business from pre-commercial startup to credible scientific partner?

Approach

Thermal partnered with Nautilus across years of company-building, from its SPAC listing to the debut of its first commercial instrument. Together, we:

• • Built and sustained a positioning strategy: From Nautilus’ public debut in 2021 through the Voyager Platform launch in 2026, we developed and consistently communicated a core narrative connecting single-molecule proteomics to tangible human health stakes, translating technically dense science for investors, journalists, and the scientific community alike.
  • Orchestrated Nautilus’ public debut as a Nasdaq-listed company: Ahead of and following the special purpose acquisition company (SPAC) merger, we drove coordinated media and thought leadership campaigns to introduce co-founders Sujal Patel and Parag Mallick and establish Nautilus as the team best positioned to lead the next era of proteomic discovery.
  • Led key launches and partnership announcements: We managed the communications rollout for Nautilus’ first commercial instrument debut, at the Human Proteome Organization’s (HUPO) US conference, the platform’s most important scientific audience. We built communications around Nautilus’ commercial entry point, positioning the Early Access Program as both a scientific proof point and a market signal, and announcing Baylor College of Medicine as its first customer. We also supported Nautilus’ partnerships with leading Alzheimer’s research institutions, including the Allen Institute, Buck Institute for Research on Aging, and The Michael J. Fox Foundation for Parkinson’s research, broadening the company’s neurodegenerative disease narrative.
  • Executed executive profiling and thought leadership campaigns: We built national platforms for Patel and Mallick through media appearances, industry events including the Tough Tech Summit and HUPO webinars, and recognition programs, positioning both founders as credible voices at the intersection of technology and life science.